Showing 21 - 40 results of 4,341 for search '"Journal for ImmunoTherapy of Cancer"', query time: 0.31s Refine Results
  1. 21
    TLR9 activation cooperates with T cell checkpoint blockade to regress poorly immunogenic melanoma

    TLR9 activation cooperates with T cell checkpoint blockade to regress poorly immunogenic melanoma by Matthew J. Reilley, Brittany Morrow, Casey R. Ager, Arthur Liu, David S. Hong, Michael A. Curran

    Published 2019-11-01
    “…Journal for ImmunoTherapy of Cancer…”
    Get full text
    Article
  2. 22
    Agonist redirected checkpoint, PD1-Fc-OX40L, for cancer immunotherapy

    Agonist redirected checkpoint, PD1-Fc-OX40L, for cancer immunotherapy by George Fromm, Suresh de Silva, Kellsey Johannes, Arpita Patel, Josiah C. Hornblower, Taylor H. Schreiber

    Published 2018-12-01
    “…Journal for ImmunoTherapy of Cancer…”
    Get full text
    Article
  3. 23
    Correction: Method for estimation of apoptotic cell fraction of cytotherapy using in vivo fluorine-19 magnetic resonance: pilot study in a patient with head and neck carcinoma receiving tumor-infiltrating lymphocytes labeled with Perfluorocarbon Nanoemulsion

    Correction: Method for estimation of apoptotic cell fraction of cytotherapy using in vivo fluorine-19 magnetic resonance: pilot study in a patient with head and neck carcinoma rece...

    Published 2023-08-01
    “…Journal for ImmunoTherapy of Cancer…”
    Get full text
    Article
  4. 24
    LAL deficiency induced myeloid-derived suppressor cells as targets and biomarkers for lung cancer

    LAL deficiency induced myeloid-derived suppressor cells as targets and biomarkers for lung cancer by Sheng Liu, Hong Du, Jun Wan, Ting Zhao, Nasser H Hanna, Shadia Jalal, Xinchun Ding, Cong Yan

    Published 2023-03-01
    “…Journal for ImmunoTherapy of Cancer…”
    Get full text
    Article
  5. 25
    244 Targeting gangliosides in pediatric cancer

    244 Targeting gangliosides in pediatric cancer by Min Huang, Guillermo N Dalton, Won-Ju Kim, Nathaniel W Mabe, Maria Caterina Rotiroti, Aidan M Tousley, Kimberly Stegmaier, Robbie G Majzner

    Published 2023-11-01
    “…Journal for ImmunoTherapy of Cancer…”
    Article
  6. 26
    VEGFR-2 redirected CAR-T cells are functionally impaired by soluble VEGF-A competition for receptor binding

    VEGFR-2 redirected CAR-T cells are functionally impaired by soluble VEGF-A competition for receptor binding by George Coukos, Evripidis Lanitis, Melita Irving, Paris Kosti, Catherine Ronet, Elisabetta Cribioli, Giorgia Rota, Aodrenn Spill, Patrick Reichenbach, Vincent Zoete, Denarda Dangaj Laniti

    Published 2021-08-01
    “…Journal for ImmunoTherapy of Cancer…”
    Get full text
    Article
  7. 27
    644 Tumor-mediated suppressive signaling and hypoxia supports altered chromatin landscapes that limit the transcriptional and functional potential of terminal T cell exhaustion

    644 Tumor-mediated suppressive signaling and hypoxia supports altered chromatin landscapes that limit the transcriptional and functional potential of terminal T cell exhaustion by Nicole Scharping, Greg Delgoffe, Paolo Vignali, Natalie Rittenhouse, Amanda Poholek, Rhodes Ford

    Published 2021-11-01
    “…Journal for ImmunoTherapy of Cancer…”
    Article
  8. 28
    366 Neoantigen-specific stimulation of T cells for effective cancer adoptive cell therapies

    366 Neoantigen-specific stimulation of T cells for effective cancer adoptive cell therapies by Steven A Rosenberg, Noam Levin, Sanghyun Kim, Charles Marquardt

    Published 2023-11-01
    “…Journal for ImmunoTherapy of Cancer…”
    Article
  9. 29
    Trial Reporting in Immuno-Oncology (TRIO): An American Society of Clinical Oncology-Society for Immunotherapy of Cancer Statement

    Trial Reporting in Immuno-Oncology (TRIO): An American Society of Clinical Oncology-Society for Immunotherapy of Cancer Statement by Apostolia M. Tsimberidou, Laura A. Levit, Richard L. Schilsky, Steven D. Averbuch, Daniel Chen, John M. Kirkwood, Lisa M. McShane, Elad Sharon, Kathryn F. Mileham, Michael A. Postow

    Published 2018-10-01
    “…Journal for ImmunoTherapy of Cancer…”
    Get full text
    Article
  10. 30
    CD4 T cell-intrinsic STING signaling controls the differentiation and effector functions of TH1 and TH9 cells

    CD4 T cell-intrinsic STING signaling controls the differentiation and effector functions of TH1 and TH9 cells by Pauline Soulas-Sprauel, Bernhard Ryffel, Corentin Richard, Romain Boidot, Elise Jacquin, Raphael Carapito, Richard A Flavell, Frederique Vegran, Tiffany Martin, Isis Benoit-Lizon, Thaiz Rivera Vargas, Aurélie Roussey, Ludivine Dal Zuffo, Andréa Melis, Daria Vinokurova, Sayyed Hamed Shahoei, Alvaro Baeza Garcia, Cassandre Pignol, Stéphane Giorgiutti, Eric R Nelson, Toby Lawrence, Lionel Apetoh

    Published 2022-01-01
    “…Journal for ImmunoTherapy of Cancer…”
    Get full text
    Article
  11. 31
    Erratum to: Differential intratumoral distributions of CD8 and CD163 immune cells as prognostic biomarkers in breast cancer

    Erratum to: Differential intratumoral distributions of CD8 and CD163 immune cells as prognostic biomarkers in breast cancer by Sotirios P. Fortis, Michael Sofopoulos, Nectaria N. Sotiriadou, Christoforos Haritos, Christoforos K. Vaxevanis, Eleftheria A. Anastasopoulou, Nicole Janssen, Niki Arnogiannaki, Alexandros Ardavanis, Graham Pawelec, Sonia A. Perez, Constantin N. Baxevanis

    Published 2017-05-01
    “…Journal for ImmunoTherapy of Cancer…”
    Get full text
    Article
  12. 32
    Incidence of thromboembolism in patients with melanoma on immune checkpoint inhibitor therapy and its adverse association with survival

    Incidence of thromboembolism in patients with melanoma on immune checkpoint inhibitor therapy and its adverse association with survival by Alok A Khorana, Tamara A Sussman, Brian Hobbs, Keith R McCrae

    Published 2021-01-01
    “…Journal for ImmunoTherapy of Cancer…”
    Get full text
    Article
  13. 33
    396 Overcoming resistance to anti-PD-1 with tumor agnostic NBTXR3: from bench to bed side

    396 Overcoming resistance to anti-PD-1 with tumor agnostic NBTXR3: from bench to bed side by Ping Zhang, Juliette Thariat, Tanguy Seiwert, Maria Angelica Cortez, Jiaxin Niu, Colette Shen, Jessica Frakes, Jared Weiss, Jimmy Caudell, Hu Yun, Sylvie Bonvalot, Zsusanna Papaï, Katherine Jameson, Patricia Said

    Published 2020-11-01
    “…Journal for ImmunoTherapy of Cancer…”
    Article
  14. 34
    870 Investigating sexual dimorphism in the tumor immune microenvironment of non-muscle invasive bladder cancer

    870 Investigating sexual dimorphism in the tumor immune microenvironment of non-muscle invasive bladder cancer by Madhuri Koti, Thiago Vidotto, David Robert Siemens, Stephen Chenard, Chelsea Jackson, Celine Hardy, Tamara Jamaspishvilli, David Berman

    Published 2020-11-01
    “…Journal for ImmunoTherapy of Cancer…”
    Article
  15. 35
    671 Update of a systematic review and meta-analysis studying the association between antibiotic use and clinical outcomes of non-small-cell lung cancer patients treated with immune checkpoint inhibitors

    671 Update of a systematic review and meta-analysis studying the association between antibiotic use and clinical outcomes of non-small-cell lung cancer patients treated with immune... by Pierre-Alain Bandinelli, Julie Cervesi, Clément Le Bescop, Renaud Buffet, Jean De Gunzburg, Gérard Zalcman

    Published 2020-11-01
    “…Journal for ImmunoTherapy of Cancer…”
    Article
  16. 36
    519 A first-in-human, multicenter, phase 1/2, open-label study of XTX101 in patients with advanced solid tumors

    519 A first-in-human, multicenter, phase 1/2, open-label study of XTX101 in patients with advanced solid tumors by John Powderly, Jennifer O’Neil, Ekta Patel, Teleen Norman, Meghan Duncan, Martin Huber, Andrae Vandross

    Published 2021-11-01
    “…Journal for ImmunoTherapy of Cancer…”
    Article
  17. 37
    324 Preclinical evaluation of anti-VISTA antibody CI-8993 in a syngeneic huVISTA-KI model

    324 Preclinical evaluation of anti-VISTA antibody CI-8993 in a syngeneic huVISTA-KI model by Christian Wichmann, Andrew Scott, Fiona Scott, Ingrid Burvenich, Alexander McDonald, Nancy Guo, Angela Rigopoulos, Raul Soikes, Steven Angelides, Reinhard von Roemeling

    Published 2021-11-01
    “…Journal for ImmunoTherapy of Cancer…”
    Article
  18. 38
    Mechanisms involved in IL-15 superagonist enhancement of anti-PD-L1 therapy

    Mechanisms involved in IL-15 superagonist enhancement of anti-PD-L1 therapy by Karin M. Knudson, Kristin C. Hicks, Sarah Alter, Jeffrey Schlom, Sofia R. Gameiro

    Published 2019-03-01
    “…Journal for ImmunoTherapy of Cancer…”
    Get full text
    Article
  19. 39
    Extensive plasma proteomic profiling revealed receptor activator of nuclear factor kappa-Β ligand (RANKL) as emerging biomarker of nivolumab clinical benefit in patients with metastatic renal cell carcinoma

    Extensive plasma proteomic profiling revealed receptor activator of nuclear factor kappa-Β ligand (RANKL) as emerging biomarker of nivolumab clinical benefit in patients with metas... by Bruno Vincenzi, Daniele Santini, Giuseppe Tonini, Sonia Simonetti, Michele Iuliani, Marco Stellato, Silvia Cavaliere, Francesco Pantano

    Published 2022-09-01
    “…Journal for ImmunoTherapy of Cancer…”
    Get full text
    Article
  20. 40
    TGFβ-specific T cells induced by a TGFβ-derived immune modulatory vaccine both directly and indirectly modulate the phenotype of tumor-associated macrophages and fibroblasts

    TGFβ-specific T cells induced by a TGFβ-derived immune modulatory vaccine both directly and indirectly modulate the phenotype of tumor-associated macrophages and fibroblasts by Mads Hald Andersen, Inés Lecoq, Evelina Martinenaite, Maria Perez-Penco, Lucia Lara de la Torre

    Published 2024-02-01
    “…Journal for ImmunoTherapy of Cancer…”
    Get full text
    Article

Search Tools: